Literature DB >> 10201591

Assessment of visual outcome after cataract surgery in patients with uveitis.

N Okhravi1, S L Lightman, H M Towler.   

Abstract

OBJECTIVE: To assess the outcome of cataract surgery in eyes of patients with uveitis.
DESIGN: Prospective, noncomparative case series. PARTICIPANTS: A total of 90 eyes of 76 patients fulfilled the enrollment criteria. INTERVENTION: All patients had their surgery performed using standard cataract extraction techniques. Unless contraindicated, preoperative systemic steroids were administered to all patients with posterior disease, chronic anterior uveitis, with known macular edema, and those in whom outcome of cataract surgery on the fellow eye had been poor.
RESULTS: Patients were divided into those with anterior disease (n = 53) and those with posterior disease (n = 37). Overall, 81 (90%) of 90 eyes showed improvement in vision (median +4 Snellen lines). In those with anterior disease, the development of severe uveitis in the first week postsurgery was associated with a greater incidence of macular edema (P = 0.014). The single largest diagnosis in those with posterior disease was that of panuveitis (n = 24). This group showed the poorest visual outcomes in this study. The majority of patients, however, were noted to have visual loss secondary to conditions present before surgery.
CONCLUSION: Cataract surgery in eyes with uveitis leads to an improvement of vision in the majority of cases. Severe postoperative uveitis is the most common postoperative complication and is associated with a significant risk of macular edema in those with anterior disease. In the posterior group, poor visual outcome after surgery is most commonly the result of preoperative vision-limiting conditions.

Entities:  

Mesh:

Year:  1999        PMID: 10201591     DOI: 10.1016/S0161-6420(99)90155-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  22 in total

Review 1.  Management of chronic uveitis.

Authors:  P J McCluskey; H M Towler; S Lightman
Journal:  BMJ       Date:  2000-02-26

2.  Outcome of phacoemulsification in patients with uveitis.

Authors:  M A Elgohary; P J McCluskey; H M A Towler; N Okhravi; R P Singh; R Obikpo; S S Lightman
Journal:  Br J Ophthalmol       Date:  2007-01-17       Impact factor: 4.638

Review 3.  Types of intraocular lenses for cataract surgery in eyes with uveitis.

Authors:  Theresa G Leung; Kristina Lindsley; Irene C Kuo
Journal:  Cochrane Database Syst Rev       Date:  2014-03-04

Review 4.  [Uveitis and the aging].

Authors:  M Zierhut; H Baatz; S Coupland; C Deuter; A Heiligenhaus; C Heinz
Journal:  Ophthalmologe       Date:  2006-09       Impact factor: 1.059

5.  Steroid prophylaxis in eyes with uveitis undergoing phacoemulsification.

Authors:  W R Meacock; D J Spalton; L Bender; R Antcliff; C Heatley; M R Stanford; E M Graham
Journal:  Br J Ophthalmol       Date:  2004-09       Impact factor: 4.638

6.  Cataract surgery in patients with history of uveitis.

Authors:  Ujwala Baheti; Sana S Siddique; C Stephen Foster
Journal:  Saudi J Ophthalmol       Date:  2012-01

7.  Comparison of intraocular lens types for cataract surgery in eyes with uveitis.

Authors:  Elizabeth Ssemanda; Kristina Lindsley; Ann-Margret Ervin; John Kempen
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

8.  Intravitreal triamcinolone acetonide injection at the time of pars plana vitrectomy for retained lens material.

Authors:  Na Rae Kim; Jun Ho Yoon; Sung Mo Kang; Hee Seung Chin
Journal:  Korean J Ophthalmol       Date:  2009-03-09

9.  Risk of hypotony in noninfectious uveitis.

Authors:  Ebenezer Daniel; Maxwell Pistilli; Siddharth S Pujari; R Oktay Kaçmaz; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; John H Kempen
Journal:  Ophthalmology       Date:  2012-07-13       Impact factor: 12.079

10.  Phacoemulsification versus small incision cataract surgery in patients with uveitis.

Authors:  Rahul Bhargava; Prachi Kumar; Shiv Kumar Sharma; Manoj Kumar; Avinash Kaur
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.